Phase II study of fixed dose-rate gemcitabine plus S-1 as second-line
- This topic has 0 replies, 1 voice, and was last updated 8 years, 5 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Phase II study of fixed dose-rate gemcitabine plus S-1 as second-line treatment in advanced biliary tract cancer.
http://abstracts.asco.org/173/AbstView_173_157741.html
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.